ArticleBioData mining2025
An explainable machine learning model for predicting postoperative cholangitis in pediatric surgical patients with pancreaticobiliary maljunction.
Article in BioData mining, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeTo develop and validate an explainable machine learning (ML) model to predict postoperative cholangitis (POC) in pediatric patients with pancreaticobiliary maljunction (PBM) using readily accessible clinical data.
methodsWe analyzed 337 children with PBM who underwent surgery, dividing them into training (n = 243, center I) and testing (n = 94, center II) sets. Six ML algorithms were applied, and the best-performing model was identified by area under the receiver operating characteristic curves (ROC-AUC) and precision-recall curves (PR-AUC). Model calibration, clinical applicability, and interpretability were further evaluated using calibration curves, decision curve analysis (DCA), and Shapley Additive Explanations (SHAP).
resultsAfter a median follow-up of 21.8 months, 13.2% (32/243) of patients from center I and 14.9% (14/94) from center II developed POC. The final random forest (RF) model exhibited the best performance, with ROC-AUC of 0.890 and PR-AUC of 0.764 in testing set, with good calibration across both sets. DCA confirmed that the final RF model was clinically useful. Nine key features were identified and ranked using SHAP analysis, with cholangial inflammatory infiltration and diameter of common bile duct being the most important.
conclusionThis explainable ML model could effectively predict POC, aiding clinicians in identifying high-risk patients and supporting individualized management in PBM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.